Table 1 Characteristics of the patients
Clinical Background | N = 1420 |
|---|---|
Age, y, mean ± SD | 69.8 ± 14.3 |
Men, n (%) | 813 (54.3) |
Hypertension, n (%) | 1076 (75.8) |
Diabetes mellitus, n (%) | 616 (43.4) |
Dyslipidemia, n (%) | 903 (63.6) |
Atrial fibrillation, n (%) | 287 (20.2) |
Coronary artery disease, n (%) | 94 (6.6) |
Congestive heart failure, n (%) | 58 (4.1) |
Thrombolytic therapy, n (%) | 147 (10.4) |
Body mass index, kg/m2, mean ± SD | 24.6 ± 4.1 |
Current smoker, n (%) | 341 (24.0) |
Cholesterol, mmol/L, mean ± SD | 4.50 ± 1.12 |
Triglyceride, mmol/L, mean ± SD | 1.38 ± 1.01 |
eGFR, mL/min per 1.73 m2, mean ± SD | 62.6 ± 29.1 |
Mean systolic blood pressure, mmHg, mean ± SD | 151.9 ± 21.2 |
Mean diastolic blood pressure, mmHg, mean ± SD | 85.8 ± 12.2 |
NIHSS on admission, median (IQR) | 4 (1–7) |
Unfavorable 3-month functional outcome, n (%) | 535 (37.7) |
Stroke subtypes, n (%) | |
 Atherothrombotic | 228 (16.1) |
 Cardioembolic | 295 (20.8) |
 Lacunar | 534 (37.6) |
 Other determined pathogenesis | 23 (1.6) |
 Undetermined pathogenesis | 340 (23.9) |